Chemical Structure (Theophylline 01)
Theophylline Tablet, Extended Release
Product Images NDC 69367-415
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 69367-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (400 mg Tablet Bottle Label)
This text describes Extended-Release Tablets containing 400 mg of Theophylline. The recommended dosage is available in the prescribing information. The tablets should be stored at 20° to 25°C (68° to 77°F) in a light-resistant and child-resistant container, as per USP guidelines. A warning to keep medications out of reach of children is also included. The product is presented in 100 Tablets and should be dispensed by prescription only.*
Principal Display Panel (600 mg Tablet Bottle Label)
This text contains information about an Extended-Release Tablet containing 600 mg of Theophylline, which is a prescription drug classified as Rx Only. The dosage instructions are not provided in this text, but it recommends referring to accompanying prescribing information. It also mentions to keep the container tightly closed and warns to keep all medications out of reach of children. The tablet is meant to be stored at room temperature. The manufacturer is Westminster Pharmaceuticals, LLC based in Kansas City, MO and Nashville, TN. Additionally, it states "MPP Pharma, LLC" was involved in manufacturing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
